The ADAP Advocacy Association (aaa+) mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. aaa+ works with advocates, community, health care, government, patients, pharmaceutical companies and other stakeholders to assure that access to services recognize and afford persons living with HIV/AIDS to enjoy a healthy life.

aaa+ is the only national grassroots organization focused exclusively on ADAPs and ensuring that there are adequate resources nationwide to eliminate or prevent waiting lists for services. Our purpose is to better engage people living with HIV/AIDS by providing a platform whereby they can offer their personal experiences, challenges, knowledge, insight and solutions to solving this perpetual problem.

 

Breaking News - 2013

ADAP Advocacy Association Issues Call for Nominations for its 2013 Annual ADAP Leadership Awards; 3rd Annual Awards Dinner to be held during 6th Annual Conference.

ADAP Advocacy Association Announces 6th Annual Conference; Event Themed ''AIDS Drug Assistance Program: Renewing the Commitment!''.

ADAP Advocacy Association releases its 2012 Congressional Scorecard evaluating Members of Congress on their support for the AIDS Drug Assistance Programs (ADAPs).

ADAP Advocacy Association Announces HIV/HCV Co-Infection Summit.

ADAP Advocacy Association Urges Anthem Blue Cross of California to Change its Mail-Order Only Pharmacy Policy for Patients Living with HIV/AIDS; Direct patient-pharmacist consultation is vital component to successful adherence and treatment.

ADAPs with Waiting Lists
(31 individuals in 3 states*, as of April 11, 2013)
Source: The ADAP Watch, National Alliance of State & Territorial AIDS Directors (NASTAD), 4/15/2013.

Florida: 0 people
Idaho: 14 people
South Dakota: 17 people

ADAPs with Other Cost-Containment Strategies
(instituted since April 1, 2012, as of February 6, 2013)

Florida: Formulary reduction
Idaho: Enrollment cap
Illinois: Formulary reduction, expenditure cap (monthly)
Indiana: Enrollment cap
Kentucky: Expenditure cap (annual)
Montana: Elimination of all support services
New Mexico: Expenditure cap (monthly)
Puerto Rico: Formulary reduction
South Dakota: Expenditure cap (annual)
Tennessee: Formulary reduction
Utah: Formulary reduction, enrollment cap
Virgin Island (U.S.): Formulary reduction
Washington: Pay insurance premiums only if client is prescribed and taking ARVs
Wyoming: Enrollment cap

ADAPs Considering New/Additional Cost-Containment Measures
(before March 31, 2013***)

Alabama: Capped enrollment / waiting list
Maine: Reduce formulary

 

ADAPs That Eliminated/Modified Cost-containment Measures
(since December 17, 2012)

North Carolina: Formulary increase

 

 

*As a result of FY2012 ADAP emergency funding, Alabama, Florida, Georgia, Idaho, Louisiana, Montana, Nebraska, North Carolina and Virginia were able to reduce the overall number of individuals on their waiting lists.
**Louiiana has a capped enrollment on their program. This number is a representation of their current unmet need.
***March 31, 2013 is the end of ADAP FY2012. ADAP fiscal years begin April 1 and ends March 31.
**** ADAPs may have eliminated/modified other cost-containment strategies prior to December 17, 2013.